The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruth, J. H.
Right arrow Articles by Chensue, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruth, J. H.
Right arrow Articles by Chensue, S. W.
The Journal of Immunology, 1998, 161: 4276-4282.
Copyright © 1998 by The American Association of Immunologists

Expression and Participation of Eotaxin During Mycobacterial (Type 1) and Schistosomal (Type 2) Antigen-Elicited Granuloma Formation1

Jeffrey H. Ruth*, Nicholas W. Lukacs{dagger}, Kelly S. Warmington*, Tim J. Polak{ddagger}, Marie Burdick{ddagger}, Steven L. Kunkel{dagger}, Robert M. Strieter{ddagger} and Stephen W. Chensue2,*,{dagger}

* Department of Pathology and Laboratory Medicine, Veterans Affairs Medical Center, and Departments of {dagger} Pathology and {ddagger} Pulmonary Medicine, University of Michigan Hospitals, Ann Arbor, MI 48105

Eotaxin participation was analyzed during types 1 and 2 lung granuloma formation induced by embolizing Sepharose beads coupled to purified protein derivative (PPD) of Mycobacterium bovis or soluble Ags derived from Schistosoma mansoni eggs. Eotaxin was monitored by protein ELISA and semiquantitative reverse-transcriptase PCR mRNA analysis. Both types 1 and 2 granulomas released eotaxin, but levels were sixfold greater (on day 4) in the type 2 than for the type 1 or foreign body granulomas. Transcripts for eotaxin, IL-4, and CCR3 (eotaxin receptor) were also enhanced during type 2 granuloma formation. Anti-IL-4 treatment impaired eotaxin mRNA in lungs with type 2 granulomas, indicating that IL-4 promoted local eotaxin expression. In vivo, anti-eotaxin treatment caused modest reductions in the size of both types 1 and 2 lesions, with negligible effect on eosinophil recruitment. Surprisingly, anti-eotaxin treatment abrogated IFN-{gamma}-producing cells in regional lymph nodes during the type 1 PPD response. Lymph nodes draining both types 1 and 2 lesions showed enhanced CCR3 mRNA, but this followed the time of maximum eotaxin protein and mRNA expression. Correlative, in vitro studies revealed that graded doses of eotaxin increased IFN-{gamma} production from PPD-sensitive regional lymph node cultures, while monocyte-chemotactic protein-1, an important macrophage chemoattractant, had the opposite effect. These findings indicate that eotaxin expression is not limited to type 2 hypersensitivity granulomas, but also promotes IFN-{gamma} production during mycobacterial responses.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. J. Haley, M. E. Sunday, Y. Porrata, C. Kelley, A. Twomey, A. Shahsafaei, B. Galper, L. A. Sonna, and C. M. Lilly
Ontogeny of the eotaxins in human lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L214 - L224.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. P. Matthews, J. S. Tregoning, A. J. Coyle, T. Hussell, and P. J. M. Openshaw
Role of CCL11 in Eosinophilic Lung Disease during Respiratory Syncytial Virus Infection
J. Virol., February 15, 2005; 79(4): 2050 - 2057.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Absood, A. Furutani, T. Kawamura, and L. M. Graham
A comparison of oxidized LDL-induced collagen secretion by graft and aortic SMCs: role of PDGF
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1200 - H1206.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
V. Pinho, S. H. Oliveira, D. G. Souza, D. Vasconcelos, A. L. Alessandri, N. W. Lukacs, and M. M. Teixeira
The role of CCL22 (MDC) for the recruitment of eosinophils during allergic pleurisy in mice
J. Leukoc. Biol., March 1, 2003; 73(3): 356 - 362.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. H. Hogan, M. Wang, M. Suresh, D. O. Co, J. V. Weinstock, and M. Sandor
CD4+ TCR Repertoire Heterogeneity in Schistosoma mansoni-Induced Granulomas
J. Immunol., December 1, 2002; 169(11): 6386 - 6393.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
X.-Z. Shang, B.-C. Chiu, V. Stolberg, N. W. Lukacs, S. L. Kunkel, H. S. Murphy, and S. W. Chensue
Eosinophil Recruitment in Type-2 Hypersensitivity Pulmonary Granulomas : Source and Contribution of Monocyte Chemotactic Protein-3 (CCL7)
Am. J. Pathol., July 1, 2002; 161(1): 257 - 266.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. K. Park, K. F. Hoffmann, A. W. Cheever, D. Amichay, T. A. Wynn, and J. M. Farber
Patterns of Chemokine Expression in Models of Schistosoma mansoni Inflammation and Infection Reveal Relationships between Type 1 and Type 2 Responses and Chemokines In Vivo
Infect. Immun., November 1, 2001; 69(11): 6755 - 6768.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
S. W. Chensue
Molecular Machinations: Chemokine Signals in Host-Pathogen Interactions
Clin. Microbiol. Rev., October 1, 2001; 14(4): 821 - 835.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Klein, A. Talvani, P. M. R. Silva, M. A. Martins, T. N. C. Wells, A. Proudfoot, N. W. Luckacs, and M. M. Teixeira
Stem Cell Factor-Induced Leukotriene B4 Production Cooperates with Eotaxin to Mediate the Recruitment of Eosinophils During Allergic Pleurisy in Mice
J. Immunol., July 1, 2001; 167(1): 524 - 531.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R.-F. Guo, A. B. Lentsch, R. L. Warner, M. Huber-Lang, J. V. Sarma, T. Hlaing, M. M. Shi, N. W. Lukacs, and P. A. Ward
Regulatory Effects of Eotaxin on Acute Lung Inflammatory Injury
J. Immunol., April 15, 2001; 166(8): 5208 - 5218.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. J. Haley, C. M. Lilly, J.-H. Yang, Y. Feng, S. P. Kennedy, T. G. Turi, J. F. Thompson, G. H. Sukhova, P. Libby, and R. T. Lee
Overexpression of Eotaxin and the CCR3 Receptor in Human Atherosclerosis : Using Genomic Technology to Identify a Potential Novel Pathway of Vascular Inflammation
Circulation, October 31, 2000; 102(18): 2185 - 2189.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Matsukawa, C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, H. L. Evanoff, and S. L. Kunkel
Pivotal Role of the CC Chemokine, Macrophage-Derived Chemokine, in the Innate Immune Response
J. Immunol., May 15, 2000; 164(10): 5362 - 5368.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Matsukawa, C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, H. L. Evanoff, R. M. Strieter, and S. L. Kunkel
Expression and Contribution of Endogenous IL-13 in an Experimental Model of Sepsis
J. Immunol., March 1, 2000; 164(5): 2738 - 2744.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Stellato, S. Matsukura, A. Fal, J. White, L. A. Beck, D. Proud, and R. P. Schleimer
Differential Regulation of Epithelial-Derived C-C Chemokine Expression by IL-4 and the Glucocorticoid Budesonide
J. Immunol., November 15, 1999; 163(10): 5624 - 5632.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. W. Chensue, K. S. Warmington, E. J. Allenspach, B. Lu, C. Gerard, S. L. Kunkel, and N. W. Lukacs
Differential Expression and Cross-Regulatory Function of RANTES During Mycobacterial (Type 1) and Schistosomal (Type 2) Antigen-Elicited Granulomatous Inflammation
J. Immunol., July 1, 1999; 163(1): 165 - 173.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.